Graham Robinson is the head of the Boston Mergers and Acquisitions Group. He focuses his practice on mergers, acquisitions and other transactions in the pharmaceutical, medical device and technology industries in the U.S. and internationally. He regularly represents public and private companies, as well as private equity and venture capital funds in acquisitions and divestitures, both negotiated and contested. He has significant experience advising companies in preparing for and responding to unsolicited acquisition proposals, as well as advising companies in dealing with activist investors. Mr. Robinson also advises companies in pharmaceutical and medical device collaborations, and issuers and underwriters in connection with initial public offerings and other corporate finance transactions.